Standex(SXI)
Search documents
STANDEX TO PARTICIPATE IN THE 37TH ANNUAL ROTH CONFERENCE
Prnewswire· 2025-03-03 13:30
Group 1 - Standex International Corporation announced participation in the 37th Annual ROTH Conference scheduled for March 16-18, 2025 [1] - Ademir Sarcevic, CFO and Treasurer of Standex, will represent the company at the conference [1] - The company's presentation will be accessible on its Investor Relations section of the website under Events and Presentations [1] Group 2 - Standex operates in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions [2] - The company has a global presence with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China [2]
STANDEX ACQUIRES MCSTARLITE
Prnewswire· 2025-02-05 21:01
SALEM, N.H., Feb. 5, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that it has acquired privately-held, California-based McStarlite Co., a leading provider of complex sheet metal aerospace components, for approximately $56.5 million in cash, financed from Standex's existing revolver. In its first year of ownership, the Company expects the acquisition to be accretive to its earnings. McStarlite Co. will be reported as part of Standex's Engineering Technologies Group busine ...
Standex(SXI) - 2025 Q2 - Quarterly Report
2025-01-31 21:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-07233 STANDEX INTERNATIONAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0596149 (State of incorporation) (IRS Employer Identification No.) ...
Standex(SXI) - 2025 Q2 - Quarterly Results
2025-01-31 18:43
Exhibit 99 NEWS RELEASE STANDEX INTERNATIONAL CORPORATION █ SALEM, NH 03079 █ TEL (603) 893-9701 █ WEB www.standex.com STANDEX REPORTS FISCAL SECOND QUARTER 2025 FINANCIAL RESULTS SALEM, NH – January 30, 2025 – Standex International Corporation (NYSE: SXI) today reported financial results for the second quarter of fiscal year 2025 ended December 31, 2024. | Summary Financial Results - Total | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | ($M except EPS and Dividends) | | 2Q25 | | ...
Standex(SXI) - 2025 Q2 - Earnings Call Presentation
2025-01-31 15:02
Second Quarter Fiscal 2025 Earnings Call Presentation January 31, 2025 SAFE HARBOR STATEMENT ▪ Q2 FY25 adjusted gross margin of 40.9% - up 60 bps YOY ▪ Q2 FY25 record adjusted operating margin of 18.7% - up 150 bps YOY; R&D expenses at 2.8% of sales with continued investments in new product development ▪ Integration of Amran/Narayan acquisition progressing ahead of plan ▪ In Q3 FY25, on a sequential basis, expect moderately to significantly higher revenue and slightly to moderately higher adjusted operating ...
Standex International (SXI) Beats Q2 Earnings and Revenue Estimates
ZACKS· 2025-01-30 23:16
Standex International (SXI) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.78 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 13.69%. A quarter ago, it was expected that this equipment manufacturing company would post earnings of $1.66 per share when it actually produced earnings of $1.71, delivering a surprise of 3.01%.Over the last ...
STANDEX REPORTS FISCAL SECOND QUARTER 2025 FINANCIAL RESULTS
Prnewswire· 2025-01-30 21:01
Core Insights - Standex International Corporation reported a net sales increase of 6.4% year-over-year for the second quarter of fiscal year 2025, reaching $189.8 million, marking the highest sales since the divestment of the Refrigeration business in April 2020 [2][3] - The company achieved a record adjusted operating margin of 18.7%, reflecting solid operational performance and contributions from the recent Amran/Narayan acquisition [3][4] - Despite the sales growth, GAAP operating income decreased by 67.2% year-over-year to $8.5 million, primarily due to increased acquisition-related costs and restructuring expenses [2][3] Financial Performance - **Net Sales**: $189.8 million in 2Q25 compared to $178.4 million in 2Q24, a 6.4% increase [2] - **Operating Income**: GAAP operating income fell to $8.5 million from $25.8 million year-over-year, while adjusted operating income rose to $35.5 million, a 15.4% increase [2][3] - **Net Income**: Net income from continuing operations decreased by 93.2% to $1.3 million [2][3] - **EBITDA**: EBITDA dropped by 50.4% to $16.1 million, with an EBITDA margin of 8.5% [2][3] Segment Performance - **Electronics**: Revenue increased by 20.8% year-over-year to $95.9 million, driven by acquisitions, although there was a 10.7% organic decline due to softness in automotive markets [5][7] - **Engraving**: Revenue decreased by 23.0% to $31.5 million, primarily due to a 22.2% organic decline [10] - **Scientific**: Revenue grew by 13.4% to $18.5 million, supported by the Custom Biogenic Systems acquisition [13] - **Engineering Technologies**: Revenue increased by 13.9% to $22.6 million, driven by favorable project timing [15] - **Specialty Solutions**: Revenue decreased by 2.9% to $21.3 million, reflecting market softness [17] Outlook - The company expects moderately to significantly higher revenue in the fiscal third quarter of 2025, driven by the Amran/Narayan acquisition and improving demand in Electronics [4][9] - Adjusted operating margins are anticipated to increase slightly to moderately, despite higher investments in selling, marketing, and R&D [4][9] Capital Allocation and Cash Flow - The company declared a quarterly cash dividend of $0.32 per share, a 6.7% increase year-over-year [23] - Free cash flow after capital expenditures was $2.2 million, down from $19.5 million in the prior year [23] - Standex's net debt increased to $413.2 million, compared to $6.2 million at the end of the previous fiscal year [23]
STANDEX DECLARES 242nd CONSECUTIVE QUARTERLY DIVIDEND
Prnewswire· 2025-01-24 14:32
SALEM, N.H., Jan. 24, 2025 /PRNewswire/ -- Standex International Corporation (NYSE: SXI) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per share, an approximately 6.7% year-on-year increase. The dividend is payable February 28, 2025, to shareholders of record on February 14, 2025. The dividend is the Company's 242nd consecutive quarterly cash dividend. Standex has paid dividends each quarter since it became a public corporation in November 1964.About StandexStan ...
STANDEX ANNOUNCES TIMING OF SECOND QUARTER FISCAL 2025 RESULTS
Prnewswire· 2025-01-24 13:30
SALEM, N.H., Jan. 24, 2025 /PRNewswire/ -- Standex International Corporation (NYSE: SXI) will announce its second quarter fiscal 2025 financial results on Thursday, January 30, 2025 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m. ET on Friday, January 31, 2025. On the call, David Dunbar, President & CEO, and Ademir Sarcevic, CFO & Treasurer, will review the Company's second quarter financial results, business highlights and outlook. Investors interest ...
STANDEX ACQUIRES CUSTOM BIOGENIC SYSTEMS
Prnewswire· 2024-11-14 21:10
Group 1 - Standex International Corporation has acquired Custom Biogenic Systems for approximately $6.2 million in cash, financed from its existing cash balance [1] - The acquisition is expected to be accretive to Standex's earnings in its first year of ownership and will be reported under the Scientific business segment [1][2] - Custom Biogenic Systems is a leader in the design and manufacturing of laboratory products, specializing in advanced cryogenic equipment, with estimated revenues of approximately $15 million for calendar year 2024 [3][4] Group 2 - The acquisition expands Standex's reach in the scientific refrigeration business, particularly in the liquid nitrogen and controlled rate freezer markets, enhancing North American manufacturing capabilities [2][4] - The addition of CBS is seen as complementary to Standex's existing product offerings, with a focus on customer intimacy and long-term combined potential [2][4] - Custom Biogenic Systems has over thirty years of industry experience, positioning it as a brand leader in cryogenic storage [4]